Evidence map›Paper›PMID 40997224›Full record

ArticleJournal of Alzheimer's disease : JAD2025

Profile and disparities in health outcomes for older adults with dual diagnoses of diabetes and Alzheimer's disease.

Alfonso Rojas-Alvarez, Hyeran Chung, Jose Eduardo Cabrero Castro, Emre Umucu

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Aging with dual burdens: cross-national evidence on mortality among older Hispanic adults with diabetes and dementia.The journals of gerontology. Series B, Psychological sciences and social sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alfonso Rojas-AlvarezDepartment of Public Health, The University of Texas at El Paso, El Paso, TX, USA.ORCID 0000-0001-7602-9596
Hyeran ChungDepartment of Economics and Finance, The University of Texas at El Paso, El Paso, TX, USA.ORCID 0009-0003-6655-9552
Jose Eduardo Cabrero CastroDepartment of Population Health and Health Disparities, The University of Texas Medical Branch, El Paso, TX, USA.ORCID 0000-0003-4976-1989
Emre UmucuDepartment of Public Health, The University of Texas at El Paso, El Paso, TX, USA.

Funding

National Alzheimer's Coordinating CenterU24AG072122 · NIA · UNIVERSITY OF WASHINGTON · PI STEPHENS, KARI A · 2021 to 2025
$45.8M
Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Katherine P Rankin · 2019 to 2026
$36.9M
Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI BRADFORD C DICKERSON · 2019 to 2026
$36.5M
UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DOUGLAS R GALASKO · 2019 to 2026
$34.9M
Wisconsin Alzheimer's Disease Research CenterP30AG062715 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Sanjay Asthana · 2019 to 2026
$34.5M
Research Education ComponentP30AG062677 · NIA · MAYO CLINIC ROCHESTER · PI KEJAL KANTARCI · 2019 to 2026
$33.5M
Research Education ComponentP30AG066514 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Margaret Sewell · 2020 to 2026
$31.0M
Yale Alzheimer Disease Research CenterP30AG066508 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER · 2020 to 2026
$30.2M
Research Education CoreP30AG066462 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PHILIP L DE JAGER · 2020 to 2026
$30.1M
Research Education ComponentP30AG066468 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI C. Elizabeth Shaaban · 2020 to 2026
$29.4M
Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI Corinne Pettigrew · 2020 to 2026
$29.3M
University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Amanda D. Boyd · 2020 to 2026
$29.0M
NCI NIH HHS U54 CA280922NIA NIH HHS P20 AG068082NIA NIH HHS P30 AG062421NIA NIH HHS P30 AG062422NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG062677NIA NIH HHS P30 AG062715NIA NIH HHS P30 AG066444NIA NIH HHS P30 AG066462NIA NIH HHS P30 AG066468NIA NIH HHS P30 AG066506NIA NIH HHS P30 AG066507NIA NIH HHS P30 AG066508NIA NIH HHS P30 AG066509NIA NIH HHS P30 AG066511NIA NIH HHS P30 AG066512NIA NIH HHS P30 AG066514NIA NIH HHS P30 AG066515NIA NIH HHS P30 AG066518NIA NIH HHS P30 AG066519NIA NIH HHS P30 AG066530NIA NIH HHS P30 AG066546NIA NIH HHS P30 AG072931NIA NIH HHS P30 AG072946NIA NIH HHS P30 AG072947NIA NIH HHS P30 AG072958NIA NIH HHS P30 AG072959NIA NIH HHS P30 AG072972NIA NIH HHS P30 AG072973NIA NIH HHS P30 AG072975NIA NIH HHS P30 AG072976NIA NIH HHS P30 AG072977NIA NIH HHS P30 AG072978NIA NIH HHS P30 AG072979NIA NIH HHS P30 AG086401NIA NIH HHS P30 AG086404NIA NIH HHS R01 AG054059NIA NIH HHS R01 AG079280NIA NIH HHS RF1 AG068988NIA NIH HHS U24 AG072122NIMHD NIH HHS P50 MD019494
6 · The paper itself

Abstract

BackgroundDiagnosis of either diabetes or Alzheimer's disease presents substantial health challenges for older adults; however, the presence of both conditions concurrently significantly exacerbates these difficulties, complicating medical management and elevating the risk of adverse health outcomes.ObjectiveGuided by syndemic theory and quantitative analyses, we examined the health profiles of older adults with dual diagnoses using national-level longitudinal data.MethodsWe utilized the Uniform Data Set (UDS) from the Alzheimer's Disease Research Centers (ADRCs) which contains demographics, neurological examination findings, and diagnoses for older adults. We analyzed 192,240 participant-visit records from 52,537 UDS participants in a pooled cross-sectional design. We conducted statistical analyses to examine disparities in health between those with dual diagnoses and those with a single diagnosis.ResultsWe found significant associations between dual diagnoses and worsened outcomes across multiple domains, including systolic blood pressure, and utilization of medications, along with higher odds of anxiety and schizophrenia, compared to those with either condition alone or neither condition. For those with Alzheimer's disease only, we find higher levels diastolic blood pressure and higher odds of speech apraxia and depression compared to the other groups. The diabetes only group has higher levels of body mass index and higher odds of hypertension and sleep disorders. These findings underscore the heightened burden of comorbidity in this population.ConclusionsFindings emphasize compounded challenges faced by older adults with dual diagnoses of diabetes and Alzheimer's disease-challenges that are not merely additive but synergistic in nature. The co-occurrence of epidemics among adults in the U.S. highlights the urgent need for policies that address their specific needs.

Indexed as

Alzheimer DiseaseDiabetes MellitusHealth Status DisparitiesAgedAged, 80 and overComorbidityCross-Sectional StudiesFemaleHumansLongitudinal StudiesMaleAlzheimer's diseasediabeteshealth disparitiesHispanicsolder adults

Identifiers

PMID40997224
PMCPMC12605309

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.